Waterfront Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$395K Buy
16,362
+83
+0.5% +$2.17K 0.06% 232
2026
Q1
$457K Sell
16,279
-1,789
-10% -$47.6K 0.08% 213
2025
Q4
$464K Sell
18,068
-409
-2% -$10.3K 0.09% 202
2025
Q3
$456K Sell
18,477
-10
-0.1% -$247 0.09% 196
2025
Q2
$448K Buy
18,487
+5,588
+43% +$130K 0.1% 196
2025
Q1
$327K Sell
12,899
-523
-4% -$13.7K 0.08% 210
2024
Q4
$356K Buy
13,422
+759
+6% +$20.6K 0.09% 206
2024
Q3
$357K Buy
12,663
+3,255
+35% +$95K 0.09% 201
2024
Q2
$263K Buy
9,408
+29
+0.3% +$798 0.07% 215
2024
Q1
$238K Sell
9,379
-146
-2% -$4.05K 0.07% 228
2023
Q4
$274K Sell
9,525
-390
-4% -$11.8K 0.08% 209
2023
Q3
$305K Sell
9,915
-52
-0.5% -$1.84K 0.1% 192
2023
Q2
$372K Sell
9,967
-680
-6% -$26.5K 0.11% 183
2023
Q1
$434K Sell
10,647
-581
-5% -$25.1K 0.14% 171
2022
Q4
$492K Buy
11,228
+270
+2% +$12.9K 0.17% 167
2022
Q3
$503K Sell
10,958
-1,052
-9% -$51.1K 0.19% 146
2022
Q2
$630K Buy
12,010
+12
+0.1% +$612 0.25% 111
2022
Q1
$657K Buy
11,998
+23
+0.2% +$1.19K 0.23% 102
2021
Q4
$707K Buy
11,975
+72
+0.6% +$3.57K 0.28% 90
2021
Q3
$512K Sell
11,903
-701
-6% -$31.1K 0.25% 98
2021
Q2
$494K Buy
12,604
+1,079
+9% +$42K 0.23% 100
2021
Q1
$418K Buy
11,525
+20
+0.2% +$710 0.21% 106
2020
Q4
$424K Buy
+11,505
New +$422K 0.3% 79

Other funds holding PFE

Waterfront Wealth's PFE Position: Q2 2026 in Review

Waterfront Wealth increased its Pfizer (PFE) stake by 0.51% in Q2 2026, buying an estimated $2.17K and bringing the position to 16,362 shares worth $395K. The position accounts for 0.06% of the portfolio, ranked #232.

Waterfront Wealth first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $707K in Q4 2021. 1,247 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Waterfront Wealth held 16,362 shares of Pfizer worth $395K as of Q2 2026.
  • Waterfront Wealth bought 83 Pfizer shares in Q2 2026, an estimated $2.17K.
  • Pfizer made up 0.06% of Waterfront Wealth's portfolio in Q2 2026, its #232 holding.
  • Waterfront Wealth first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
  • Waterfront Wealth's Pfizer position peaked at $707K in Q4 2021.
  • 1,247 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Waterfront Wealth's 13F filing for Q2 2026, filed 30 Jul 2026.